139 related articles for article (PubMed ID: 30816163)
1. A novel liver-specific fluorescent anti-cancer drug delivery system using indocyanine green.
Inagaki Y; Kokudo T; Kamiya M; Uno SN; Sato M; Kaneko J; Kokudo N; Urano Y; Hasegawa K
Sci Rep; 2019 Feb; 9(1):3044. PubMed ID: 30816163
[TBL] [Abstract][Full Text] [Related]
2. Long-circulating and liver-targeted nanoassemblies of cyclic phosphoryl N-dodecanoyl gemcitabine for the treatment of hepatocellular carcinoma.
Du L; Zhang B; Lei Y; Wang S; Jin Y
Biomed Pharmacother; 2016 Apr; 79():208-14. PubMed ID: 27044830
[TBL] [Abstract][Full Text] [Related]
3. Near-infrared fluorescence imaging and photodynamic therapy with indocyanine green lactosome has antineoplastic effects for hepatocellular carcinoma.
Tsuda T; Kaibori M; Hishikawa H; Nakatake R; Okumura T; Ozeki E; Hara I; Morimoto Y; Yoshii K; Kon M
PLoS One; 2017; 12(8):e0183527. PubMed ID: 28859104
[TBL] [Abstract][Full Text] [Related]
4. The Application of Heptamethine Cyanine Dye DZ-1 and Indocyanine Green for Imaging and Targeting in Xenograft Models of Hepatocellular Carcinoma.
Zhang C; Zhao Y; Zhang H; Chen X; Zhao N; Tan D; Zhang H; Shi C
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28635650
[TBL] [Abstract][Full Text] [Related]
5. Development of Asialoglycoprotein Receptor-Targeted Nanoparticles for Selective Delivery of Gemcitabine to Hepatocellular Carcinoma.
Nair AB; Shah J; Al-Dhubiab BE; Patel SS; Morsy MA; Patel V; Chavda V; Jacob S; Sreeharsha N; Shinu P; Attimarad M; Venugopala KN
Molecules; 2019 Dec; 24(24):. PubMed ID: 31847085
[TBL] [Abstract][Full Text] [Related]
6. Encapsulated microRNA by gemcitabine prodrug for cancer treatment.
Zhang HT; Sun J; Yan Y; Cui SH; Wang H; Wang CH; Qiu C; Chen X; Ding JS; Qian HG; Wang JC; Zhang Q
J Control Release; 2019 Dec; 316():317-330. PubMed ID: 31733293
[TBL] [Abstract][Full Text] [Related]
7. Self-assembled drug delivery systems. Part 6: in vitro/in vivo studies of anticancer N-octadecanoyl gemcitabine nanoassemblies.
Jin Y; Lian Y; Du L; Wang S; Su C; Gao C
Int J Pharm; 2012 Jul; 430(1-2):276-81. PubMed ID: 22486963
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of fluorescence imaging with indocyanine green in hepatocellular carcinoma.
Kaibori M; Matsui K; Ishizaki M; Iida H; Sakaguchi T; Tsuda T; Okumura T; Inoue K; Shimada S; Ohtsubo S; Kusano M; Ikehara Y; Ozeki E; Kitawaki T; Kon M
Cancer Imaging; 2016 Apr; 16():6. PubMed ID: 27052371
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of indocyanine green injection during ultrasound-guided liver biopsy for the diagnosis of small hepatocellular carcinoma.
Kimura Y; Higashi T; Kuwahara N; Nouso K; Ohguchi S; Hino N; Tanimizu M; Nakatsukasa H; Tobe K; Tsuji T
Acta Med Okayama; 1996 Oct; 50(5):255-9. PubMed ID: 8914678
[TBL] [Abstract][Full Text] [Related]
10. Nanotechnology improves the therapeutic efficacy of gemcitabine against a human hepatocellular carcinoma cell line and minimizes its in vivo side effects.
El-Sheikh SMA; Khairy MH; Osama E; Metwally MMM; Galal AAA
Naunyn Schmiedebergs Arch Pharmacol; 2021 Apr; 394(4):631-643. PubMed ID: 33104848
[TBL] [Abstract][Full Text] [Related]
11. Real-time identification of liver cancers by using indocyanine green fluorescent imaging.
Ishizawa T; Fukushima N; Shibahara J; Masuda K; Tamura S; Aoki T; Hasegawa K; Beck Y; Fukayama M; Kokudo N
Cancer; 2009 Jun; 115(11):2491-504. PubMed ID: 19326450
[TBL] [Abstract][Full Text] [Related]
12. A Novel Color-Coded Liver Metastasis Mouse Model to Distinguish Tumor and Adjacent Liver Segment.
Nishino H; Hollandsworth HM; Amirfakhri S; Tashiro Y; Yamamoto J; Turner MA; Lwin TM; Singer BB; Hoffman RM; Bouvet M
J Surg Res; 2021 Aug; 264():327-333. PubMed ID: 33848831
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic background and clinical applications of indocyanine green fluorescence imaging of hepatocellular carcinoma.
Ishizawa T; Masuda K; Urano Y; Kawaguchi Y; Satou S; Kaneko J; Hasegawa K; Shibahara J; Fukayama M; Tsuji S; Midorikawa Y; Aburatani H; Kokudo N
Ann Surg Oncol; 2014 Feb; 21(2):440-8. PubMed ID: 24254203
[TBL] [Abstract][Full Text] [Related]
14. Indocyanine green fluorescent imaging for detecting extrahepatic metastasis of hepatocellular carcinoma.
Satou S; Ishizawa T; Masuda K; Kaneko J; Aoki T; Sakamoto Y; Hasegawa K; Sugawara Y; Kokudo N
J Gastroenterol; 2013 Oct; 48(10):1136-43. PubMed ID: 23179608
[TBL] [Abstract][Full Text] [Related]
15. Antiangiogenic and antitumor effects of a protein kinase C beta inhibitor in human hepatocellular and gastric cancer xenografts.
Teicher BA; Menon K; Alvarez E; Liu P; Shih C; Faul MM
In Vivo; 2001; 15(3):185-93. PubMed ID: 11491013
[TBL] [Abstract][Full Text] [Related]
16. Prospective randomised phase II study of gemcitabine at standard or fixed dose rate schedule in unresectable hepatocellular carcinoma.
Guan Z; Wang Y; Maoleekoonpairoj S; Chen Z; Kim WS; Ratanatharathorn V; Reece WH; Kim TW; Lehnert M
Br J Cancer; 2003 Nov; 89(10):1865-9. PubMed ID: 14612894
[TBL] [Abstract][Full Text] [Related]
17. A novel treatment strategy using indocyanine green for transarterial chemoembolization in BCLC stage C hepatocellular carcinoma.
Mei J; Li SH; Wang QX; Zhong XP; Lu LH; Kan A; Wei W; Guo RP
Cancer Med; 2020 Jan; 9(1):62-76. PubMed ID: 31701652
[TBL] [Abstract][Full Text] [Related]
18. Use of magnetic resonance elastography for assessing liver functional reserve: A clinical study.
Li B; Min J; Liang WR; Zhang GQ; Wu JJ; Jin K; Huang W; Ying CY; Chao M
World J Gastroenterol; 2015 Jun; 21(24):7522-8. PubMed ID: 26139999
[TBL] [Abstract][Full Text] [Related]
19. Indocyanine Green Labeling of Tumors in the Liver Recurring After Radiofrequency Ablation Enables Complete Resection by Fluorescence-guided Surgery.
Tashiro Y; Aoki T; Hirai T; Koizumi T; Kusano T; Matsuda K; Yamada K; Nogaki K; Hakozaki T; Wada Y; Shibata H; Tomioka K; Yamazaki T; Saito K; Fujimori A; Enami Y; Hoffman RM
Anticancer Res; 2022 Mar; 42(3):1345-1350. PubMed ID: 35220226
[TBL] [Abstract][Full Text] [Related]
20. Near-infrared photothermal/photodynamic therapy with indocyanine green induces apoptosis of hepatocellular carcinoma cells through oxidative stress.
Shirata C; Kaneko J; Inagaki Y; Kokudo T; Sato M; Kiritani S; Akamatsu N; Arita J; Sakamoto Y; Hasegawa K; Kokudo N
Sci Rep; 2017 Oct; 7(1):13958. PubMed ID: 29066756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
